Trial Profile
The comparative study between direct renin inhibitor and angiotensin II receptor antagonist in hypertensive patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2012
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 18 Jul 2012 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 18 Jul 2012 Actual initiation date (Oct 2010) added as reported by University Hospital Medical Information Network - Japan.
- 10 May 2012 New trial record